|
Status |
Public on Jan 03, 2012 |
Title |
untransduced |
Sample type |
SRA |
|
|
Source name |
untransduced
|
Organism |
Homo sapiens |
Characteristics |
chip antibody: Combined anti-DUX4 C-terminus rabbit polyclonal antibodies MO488 and MO490 cell type: human myoblasts
|
Growth protocol |
Primary myoblasts grown in F-10 nutrient media, 20% FBS, 1% Pen/Strep, 10 ng/ml bFGF and 1 µM Dexamethasone.
|
Extracted molecule |
genomic DNA |
Extraction protocol |
Standard Illumina ChIP-seq sample prep kit protocol with two modifications: (1) DNA fragments ranging from 150 to 300 bp were selected at the gel-selection step; (2) 21 cycles of PCR were performed at the PCR amplification step instead of 18.
|
|
|
Library strategy |
ChIP-Seq |
Library source |
genomic |
Library selection |
ChIP |
Instrument model |
Illumina Genome Analyzer IIx |
|
|
Data processing |
Sequence reads were obtained using the Illumina Genome Analyzer IIx. Reads were aligned to human genome (hg18) using BWA. Peaks are called using in-house developed R package peakSig.
|
|
|
Submission date |
Nov 21, 2011 |
Last update date |
May 15, 2019 |
Contact name |
Stephen Tapscott |
E-mail(s) |
stapscot@fredhutch.org
|
Organization name |
Fred Hutch Cancer Research Center
|
Department |
Human Biology
|
Lab |
Tapscott
|
Street address |
1100 Fairview N. Ave
|
City |
Seattle |
State/province |
WASHINGTON |
ZIP/Postal code |
98103 |
Country |
USA |
|
|
Platform ID |
GPL10999 |
Series (1) |
GSE33838 |
DUX4 activates germline genes, retroelements and immune-mediators: Implications for facioscapulohumeral dystrophy |
|
Relations |
SRA |
SRX107285 |
BioSample |
SAMN00760376 |